Database Proof Substratum: Substratum of Proof LGBTQs Are Mentally Ill: Dthera Sciences Receives FDA Breakthrough Device Designation For Its Alzheimer’s Focused Development-Stage Product “DTHR-ALZ”

Gendrome Editors' Note: The article below provides the raw material for a proof and is not the proof itself. In addition, the raw material may contain one or more false statements and/or some offensive, outside content.

Dthera(tm) Sciences (OTCQB:DTHR), the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.